U7B-29342-90333
4 vaccinations
3 coded responses
43 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 604 / IL
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3A4-27748-24269
Child or adolescent in my care · Female · 2022-06-24
5RB-17145-97680
Child or adolescent in my care · Female · 2022-06-24
FVA-33008-05540
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Site: PainFree text: Headache very mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
-
2021-02-11
Survey response — day 35, dose 2MedDRA: Diarrhoea, Headache — Feeling: GoodFree text: Diarrhea (today) & headache (today)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Back pain, Headache — Feeling: GoodFree text: Headaches and lower back painMedDRA releases: 2024-11 · check-in free text available
- 2022-03-31
-
2022-09-22
Dose 4 — Pfizer-BioNTech
- 2022-09-27
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-29
- 2022-11-03
- 2022-12-22
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Headache very mild
Release 4 — day 35, dose 2
Symptoms: Diarrhea (today) & headache (today)
Release 10 — 3 months, dose 3
Symptoms: Headaches and lower back pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release